PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAG9. A total of 15 filers reported holding PDL BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,161,506,000 | +94.8% | 4,100,000 | +106.5% | 0.95% | -6.9% |
| Q2 2020 | $2,136,019,000 | -0.7% | 1,985,000 | -1.2% | 1.02% | -17.4% |
| Q1 2020 | $2,151,162,000 | -7.3% | 2,010,000 | -5.2% | 1.23% | +41.7% |
| Q4 2019 | $2,319,937,000 | +12.1% | 2,120,000 | -2.3% | 0.87% | +11.7% |
| Q3 2019 | $2,069,733,000 | -37.8% | 2,170,000 | -31.5% | 0.78% | -36.9% |
| Q2 2019 | $3,327,834,000 | -10.3% | 3,170,000 | -2.3% | 1.24% | -11.0% |
| Q1 2019 | $3,711,469,000 | +12.8% | 3,245,000 | -0.2% | 1.39% | +2.2% |
| Q4 2018 | $3,291,210,000 | +2.3% | 3,250,000 | -0.3% | 1.36% | +22.3% |
| Q3 2018 | $3,217,213,000 | +114.0% | 3,260,000 | +98.8% | 1.11% | +112.0% |
| Q2 2018 | $1,503,691,000 | – | 1,640,000 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SMH CAPITAL ADVISORS INC | 13,002,000 | $11,937,000 | 19.35% |
| Context Capital Management, LLC | 8,175,000 | $7,546,000 | 6.49% |
| Venator Capital Management Ltd. | 2,000,000 | $1,854,000 | 1.27% |
| LINDEN ADVISORS LP | 27,867,000 | $25,654,000 | 0.79% |
| WHITEBOX ADVISORS LLC | 22,181,000 | $20,365,000 | 0.66% |
| Pinnacle Holdings, LLC | 1,640,000 | $1,503,691,000 | 0.52% |
| WOLVERINE ASSET MANAGEMENT LLC | 16,852,000 | $15,400,000 | 0.20% |
| OAKTREE CAPITAL MANAGEMENT LP | 5,060,000 | $4,670,000 | 0.06% |
| AQR Arbitrage LLC | 3,150,000 | $2,908,000 | 0.04% |
| KENNEDY CAPITAL MANAGEMENT LLC | 1,000,000 | $917,000 | 0.02% |